Senate Health Cmte. Chairman Enzi Addresses FDLI April 7
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA drug safety issues are expected to highlight both Enzi’s and Commissioner-nominee Crawford’s keynote presentations. Additional speakers at the regulatory group’s annual meeting include CMS Administrator McClellan, HHS General Counsel Azar.